FDA Authorizes Experimental NOVAVAX Jab Without Any Clinical Trial Data

The agency also relied on its evaluation of safety and effectiveness data from clinical trials of Novavax COVID-19, Vaccine, Adjuvanted (Original monovalent) and investigational monovalent and bivalent Novavax COVID-19 adjuvanted vaccines, as well as postmarketing data.

While the original Novavax Covid vaccines were analyzed in clinical trials, the FDA authorized the use of the new Novavax Covid vaccine (for more current Covid variants) under EUA without clinical trials being done on the updated version.

The data accrued with these Novavax COVID-19 vaccines are relevant to Novavax COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) as the vaccines are manufactured using a similar process,” an FDA press release said on October 3, 2023.

The Novavax Covid jab uses experimental vaccine technology that is said to be even more radical than mRNA.

Biden’s FDA has authorized the use of a new and experimental Covid vaccine from Novamax under emergency use authorization, despite the fact that it hasn’t been tested on humans and does not have a licence.

Refer to the full Fact Sheet for information about the Novavax COVID-19 Vaccine, Adjuvanted,” the Novavax website said.

“The Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) has not been approved or licensed by FDA, but has been authorized for emergency use by FDA, under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) in individuals 12 years of age and older. 

https://thepeoplesvoice.tv/fda-authorizes-experimental-novavax-jab-without-any-clinical-trial-data/